{"name":"Lantu Biopharma","slug":"lantu-biopharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxNNzg2TG1VWW1CdXdkQUFuUzRVd0JGQ0x0OEMyQ2p6OWh1QjRnXy1fUXQzTFJyRkpWdEVaZ0t6R21qelJjVEpjRzdTMnU1S0M4dVphZ1o1aGhiVEx6ams2QjFVQ1ROSkV0RkwtU1c0SjVDZUJoZ1JLczFveEhXekxHOGtadF9IR193bVhMVFhiSThlNk9TaFl2TVYzcVA1ajFMbjFqbDRmTkJnMXVKUmh0YldiZVh6QkVWSnM3QUpCTmhYdEh3c3RMS2NlOWo4NzNQMkhaVmp6Q0Vmdnp6OUNsT2hONWh4ek5ZZDRIdWFXeDJKbm5kbjlNY05lMnhyTzRGRkRaeXlFZFM4MUtVbmg1M1BKWFc?oc=5","date":"2026-04-01","type":"trial","source":"Barchart.com","summary":"AAV Vectors in Gene Therapy Clinical Trial Pipeline Accelerates as 180+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Barchart.com","headline":"AAV Vectors in Gene Therapy Clinical Trial Pipeline Accelerates as 180+ Pharma Companies Rigorously Develop Drugs for Ma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxObk1zV3o2Znd0TW42d0g3S1R1S1BpRmdNVWVQU1gtdHptMmYzZk1RSTNXRXpmWFE1dmNOcnNzOUY5Slo2Q3o3WWhGN2trcWJzZGJuQWx1dVhIT0lJYm1lZmt1eVNfX1FVcUlaTkNIQVFhbnlOSFNRMmw1YktBUDdwS00wamxtOGpNTXh2Nkln?oc=5","date":"2025-10-09","type":"trial","source":"Endpoints News","summary":"In China, a low-cost push to rival a life-saving, $2M medicine - Endpoints News","headline":"In China, a low-cost push to rival a life-saving, $2M medicine","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-04-15","type":"pipeline","source":"The Economic Times","summary":"Sweet Surrender: Sanofi puts star insulin brand Lantus up for sale, eyes Rs 2,000 cr from Indian pharma gi - The Economic Times","headline":"Sweet Surrender: Sanofi puts star insulin brand Lantus up for sale, eyes Rs 2,000 cr from Indian pharma gi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNcUNyekJfRXJJSEdmRU5ueDdzUHN1cUFPR1RHLXc4NVlLc3VseUVUSzVGSUNQTUJSNlk3OW0wcjI4WTgySFVzTmt6Z1BXdEhSWDBEOUNUOHlwQlJ5aHRJRk52MlR6ZXNZZS1aZ3hBOGdUa0VZTS1HcV95WTFXOTNMUnU1Vy1RcmdPdm9rSWJTUE4zSHJmWEVLZ1BSZmlYSDV3SzlkbUJuMDZldE53?oc=5","date":"2023-03-17","type":"pipeline","source":"Fierce Pharma","summary":"Sanofi answers the call, joining Eli Lilly, Novo Nordisk in cutting insulin prices - Fierce Pharma","headline":"Sanofi answers the call, joining Eli Lilly, Novo Nordisk in cutting insulin prices","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPTWJLcHAyRUJkcDk3eDN5V0RVNF9hNjhRUWFYTlFhYmdqQVlhQTBSZWp1eTZOdUxlTFRYR1pnUmVZX3ZYOWJzRXBnOVNKeWpmUXUzTzRMb3dpenE5UVV6eVhnbGtOb2NzMVF1WVdOLTNQX2xya0ZmLUt6LU0zRUt5ZzB2TXN4UkY5NEVzbzJnTlJCMlhoZ1k3VkxVb2VxZ0tuNWFZSmo3MG1RRDVtWFRHUlZ3cVF1Q25oVnd1MXB0YkF2TlllV0ZNTXFGbw?oc=5","date":"2022-08-24","type":"trial","source":"Technology Networks","summary":"VectorBuilder Supports First Gene Therapy Trial for Menkes Disease - Technology Networks","headline":"VectorBuilder Supports First Gene Therapy Trial for Menkes Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPZ202Y2oxc25XczV1cGdDZ19UczNRTFlZTXM4T1JwQ0oxRmN2ZmxQSXhwUlZ6LVdvMUFZS3A5UmxfQWpVbG1sNXRROU9zdnZ0bUpxSlRsOW1POWZrSHpEOGVDUlJjeXNnQ1g5VGZidE10dEJqYlhXUXZIb05IZ1FzN0N5MEJqZUxfRV9UcTdIbS02T3hUUHN3VUxQT2l0VlRHNnlNNHpBdkI?oc=5","date":"2020-09-01","type":"pipeline","source":"Fierce Pharma","summary":"Mylan, Biocon undercut insulin competitors on price with launch of Lantus copycat - Fierce Pharma","headline":"Mylan, Biocon undercut insulin competitors on price with launch of Lantus copycat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQWWhwUnJYNThvdWhxdVdiTVZVYkNhMWxoU05jQTI4bE9QdVJ5NXppeU1FYUNSWUZSYjE4X2o1dUx0a0dWdzlOOTV0aVNIMGd4Z2N0UVBmdDRQYmdxTkZJTExIM1Q5akFHUlZ1V0ZPNHRtbVdpTC1heVBRenhubnYwdDQ5cUkyRjE1NUEtU1NaVkRKd1pCSjdzRDVOMGV3eUVOT0tTelM5YXk?oc=5","date":"2018-11-02","type":"patent","source":"BioPharma Dive","summary":"Insulin drugmakers under scrutiny for pricing, patent practices - BioPharma Dive","headline":"Insulin drugmakers under scrutiny for pricing, patent practices","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOcGM5YWQyY3VTVFBYWUxYWlA2YjR6NDlsN0UwR1JDR1dBVHdqOGtkS05TLU5XZFpXMmFHTDQxZXR4VWcyejVsQVhCdk9SMnVlSW9HUXc0ZmV0MUVncXF4UXNmd3JWMTI5RkpLRlU4MmN0Qzh4YnI4TVVrOVQ2YzNfaTNXTnpUb1hqa0xMUGVnZ05PN3c?oc=5","date":"2018-10-12","type":"pipeline","source":"BioPharma Dive","summary":"Merck, Samsung Bioepis end development on copy of Sanofi’s Lantus - BioPharma Dive","headline":"Merck, Samsung Bioepis end development on copy of Sanofi’s Lantus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOT2g4a2Q1RXFrLTFyOE11c0JNWW81VWtzOUN5aGxBT3A4NFhfUU5FTDVHcUg5azdmNHNLS1hkNEF3dTRpSkhHX3haa2lwLUUyWnptNGZxbmJ0bENHb01vSWtxREdnRkY0OXJVeDdVLTBsVXkxWUg3c1ZMZTlLLU9XN25UUnZNQVZQZjQ4a090OFN6ZkpMdGlSMVBPMm1BeUVkUU9fclEyQ0NlZXZvX0FEREFmc3lNS05NNllRZA?oc=5","date":"2018-10-12","type":"patent","source":"Fierce Pharma","summary":"Merck ditches biosimilar Lantus, but will that ease the path for Mylan’s rival insulin product? - Fierce Pharma","headline":"Merck ditches biosimilar Lantus, but will that ease the path for Mylan’s rival insulin product?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxObU1xMERnVFUwRklKX2w4SlZVVXNNVnota04ya3dLdkR2RmhxdlRkcVNDeUZPalctV2pWT1hMTmRkQzZwa1RkYVI5Z3dadjh1X0xFQU1PRWkwallIbW1wb1IxUThnZ0xLZnJZN1FPZUtONHdFLXdncVNSTHdBS1dHUzNob1gtU2RVLTJjZGpwaFNZLS14MklWUm03ZF9PMnExTFhF?oc=5","date":"2018-06-05","type":"regulatory","source":"Fierce Pharma","summary":"No surprise: FDA hits Mylan and Biocon with CRL for their follow-on copy of Lantus - Fierce Pharma","headline":"No surprise: FDA hits Mylan and Biocon with CRL for their follow-on copy of Lantus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNX0s5SDRnWDlWVGZzX09RLWhOeUxJNm1tNHBFeTA4SUl6clhqc0wxSnU2T1FOdzRGVkItcndRTjNzSnpCNjFEMnV4bVJyU3lsZW5Rcnc5LThWRk5yZDByYVdZUUFCMDVlMUN4aEtXUzJLTW5OeTUzT3lCcDd2VS1iYW5YTjJMTUpKQm1PcjMxR1Bpdw?oc=5","date":"2016-09-20","type":"patent","source":"BioPharma Dive","summary":"Sanofi aims to block Merck’s Lantus biosimilar - BioPharma Dive","headline":"Sanofi aims to block Merck’s Lantus biosimilar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPd1ByY3p2Mi02SjR3dkV1QXliUVZpUHFHUHFLal9WVVZaSlJlbUZDbGw1TVAxRGJMSWZBa1lGdlA1bFVmc0tyMnZYQzNEOWJyUU9BOV9iRl94cDN3TGNaRm8xc1MwTXk4Y2dxWDczMUdhY2xia1JqVzF4bVQtYWYwaHlSNWtTaDNMTUo1SA?oc=5","date":"2016-08-10","type":"pipeline","source":"BioPharma Dive","summary":"Why certain drugs don’t make the formulary - BioPharma Dive","headline":"Why certain drugs don’t make the formulary","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}